Company / Working Capital per Share
AGIOS PHARMACEUTICALS, INC. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$15.04
FY2025
5-year range
$13.92 / $16.62
FY2021-FY2025
Trend
-4.8%
vs FY2024
Sector context
#28 of 210
Health Care
What the data says
AGIOS PHARMACEUTICALS, INC.'s working capital per share of $15.04 is higher than 87% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $7.93 in FY2020 to $16.62 in FY2021.
Based on SEC 10-K filings.
15.04 in FY2025 with a 5-year CAGR of +13.7%. Top quartile in the Health Care sector.
Improved from $13.92 to $15.04 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +2.0%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Sector benchmark
-87.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 4.8% year-over-year.
- Ranks #28 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.04 | -4.8% |
| FY2024 | $15.81 | +13.6% |
| FY2023 | $13.92 | -1.8% |
| FY2022 | $14.17 | -14.7% |
| FY2021 | $16.62 | +109.6% |
| FY2020 | $7.93 | -11.0% |
| FY2019 | $8.91 | -16.4% |
| FY2018 | $10.66 | +28.4% |
| FY2017 | $8.30 | -33.7% |
| FY2016 | $12.51 | +63.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026